TELESCOPE, Remote Decision Coaching with Navigation Intervention for Lung Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Rutgers, Cancer Institute of New Jersey, New Brunswick, NJ
Lung Cancer
TELESCOPE, Remote Decision Coaching with Navigation Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Lung Cancer

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: The change in baseline, three months and five years

The change in baseline, three months and five years
Completion of diagnostic testing
Receipt of tobacco treatment
To assess hared decision making
Tobacco treatment referral

Trial Safety

Safety Progress

1 of 3

Other trials for Lung Cancer

Trial Design

2 Treatment Groups

Enhanced usual care (EUC)
1 of 2
TELESCOPE intervention
1 of 2
Active Control
Experimental Treatment

420 Total Participants · 2 Treatment Groups

Primary Treatment: TELESCOPE, Remote Decision Coaching with Navigation Intervention · No Placebo Group · N/A

TELESCOPE intervention
Behavioral
Experimental Group · 1 Intervention: TELESCOPE, Remote Decision Coaching with Navigation Intervention · Intervention Types: Behavioral
Enhanced usual care (EUC)NoIntervention Group · 1 Intervention: Enhanced usual care (EUC) · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: the change in baseline, three months and five years
Closest Location: Rutgers, Cancer Institute of New Jersey · New Brunswick, NJ
Photo of new jersey 1Photo of new jersey 2Photo of new jersey 3
N/AFirst Recorded Clinical Trial
0 TrialsResearching Lung Cancer
0 CompletedClinical Trials

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,390 Previous Clinical Trials
24,521,137 Total Patients Enrolled
Rutgers, The State University of New JerseyLead Sponsor
361 Previous Clinical Trials
59,767 Total Patients Enrolled
Anita Y Kinney, PhDPrincipal InvestigatorRutgers Cancer Institute of New Jersey

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Inclusion criteria: You are 18 years or older.
You have a 20 pack-year smoking history.
Subjects were interviewed at the study sites.
You are fluent in English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.